Terms: = Leukemia AND MLLT11, Q13015, 10962, ENSG00000213190, AF1Q AND Treatment
2 results:
1. Novel af1q/mllt11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia.
Li W; Ji M; Lu F; Pang Y; Dong X; Zhang J; Li P; Ye J; Zang S; Ma D; Ji C
Cell Death Dis; 2018 Aug; 9(9):855. PubMed ID: 30154435
[TBL] [Abstract] [Full Text] [Related]
2. Oncogene af1q enhances doxorubicin-induced apoptosis through BAD-mediated mitochondrial apoptotic pathway.
Co NN; Tsang WP; Wong TW; Cheung HH; Tsang TY; Kong SK; Kwok TT
Mol Cancer Ther; 2008 Oct; 7(10):3160-8. PubMed ID: 18852119
[TBL] [Abstract] [Full Text] [Related]
